This press release is being issued in accordance with the early warning requirements of applicable Canadian securities laws. On November 10, 2025, Don. T. Gray acquired 81,900 common shares ("Shares") ...
Bipartisan Senate bill proposes CFTC oversight and dual regulation with the SEC. The draft is the first step for US crypto ...
Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the third quarter of 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback